![](/img/cover-not-exists.png)
P243 Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates for adalimumab-treated patients with early Crohn's disease
S. Schreiber, W. Reinisch, J.-F. Colombel, W. Sandborn, A. Robinson, B. Huang, K. Lomax, P. PollackVolume:
6
Year:
2012
Language:
english
DOI:
10.1016/s1873-9946(12)60263-3
File:
PDF, 49 KB
english, 2012